CYP2D6 adverse events autism pharmacogenetics polypharmacy

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
03 Jul 2023
Historique:
received: 18 05 2023
revised: 23 06 2023
accepted: 28 06 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

The long-term use of psychopharmacology medications in autism spectrum disorder (ASD) hitherto remains controversial due to a lack of evidence about safety and tolerability. In this regard, genotyping the metabolizing enzyme cytochrome P450

Identifiants

pubmed: 37513866
pii: ph16070954
doi: 10.3390/ph16070954
pmc: PMC10385457
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cochrane Database Syst Rev. 2012 May 16;(5):CD009043
pubmed: 22592735
Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):177-206
pubmed: 16321730
Philos Trans A Math Phys Eng Sci. 2008 Jul 13;366(1874):2377-88
pubmed: 18407900
Genet Med. 2017 Jan;19(1):69-76
pubmed: 27388693
Expert Opin Drug Saf. 2016 Nov;15(11):1477-1482
pubmed: 27551945
Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):596-605
pubmed: 29325225
Pharmacogenomics J. 2016 Oct;16(5):485-90
pubmed: 27272044
Medicine (Baltimore). 2017 Nov;96(45):e8505
pubmed: 29137046
Autism. 2017 Nov;21(8):995-1009
pubmed: 27875247
J Clin Pharmacol. 2015 Oct;55(10):1167-74
pubmed: 25919121
Acta Psychiatr Scand. 2017 Jan;135(1):8-28
pubmed: 27624381
Pain Med. 2009 Jul-Aug;10(5):799-805
pubmed: 19523031
J Clin Invest. 2008 Jan;118(1):6-14
pubmed: 18172517
J Autism Dev Disord. 2017 Jan;47(1):187-202
pubmed: 27807754
JAMA. 2009 Oct 28;302(16):1765-73
pubmed: 19861668
Expert Opin Pharmacother. 2016;17(7):937-52
pubmed: 26891879
Psychiatry Res. 2020 Oct;292:113321
pubmed: 32738553
Clin Toxicol (Phila). 2015 Jul;53(6):501-10
pubmed: 25998998
Drug Metab Pharmacokinet. 2016 Apr;31(2):156-62
pubmed: 26944100
Expert Opin Drug Metab Toxicol. 2014 Nov;10(11):1569-83
pubmed: 25316321
Pharmgenomics Pers Med. 2020 Mar 13;13:71-79
pubmed: 32214840
Clin Transl Sci. 2020 Jan;13(1):116-124
pubmed: 31647186
J Autism Dev Disord. 2010 Nov;40(11):1361-70
pubmed: 20309621
Int Rev Neurobiol. 2008;83:1-10
pubmed: 18929073
Clin Pharmacokinet. 2004;43(14):983-1013
pubmed: 15530129
Clin Pharmacol Ther. 2014 Apr;95(4):376-82
pubmed: 24458010
Ann Pharmacother. 2013 Mar;47(3):350-60
pubmed: 23463739
J Autism Dev Disord. 2014 Dec;44(12):3063-71
pubmed: 24958436
Mol Diagn Ther. 2013 Jun;17(3):165-84
pubmed: 23588782
Pharmgenomics Pers Med. 2016 Dec 01;9:131-147
pubmed: 27942231
J Clin Psychopharmacol. 2004 Dec;24(6):647-52
pubmed: 15538128
J Child Adolesc Psychopharmacol. 2017 Mar;27(2):185-191
pubmed: 26780783
Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):621-629
pubmed: 29575226
Front Psychiatry. 2018 Jan 24;9:2
pubmed: 29472872
Drug Metab Pharmacokinet. 2014;29(1):29-43
pubmed: 23759977
Autism Res. 2017 Dec;10(12):2037-2047
pubmed: 28963809

Auteurs

Pura Ballester (P)

Pharmacology Department, Pharmacy Degree, San Antonio Catholic University, 30107 Murcia, Spain.

Cristina Espadas (C)

Bioengineering Institute, Pediatrics and Organic Chemistry Department, Miguel Hernández University of Elche (UMH), 03202 Alicante, Spain.

Susana Almenara (S)

Neuropharmacology on Pain Treatment and Neurodevelopmental Disorders, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Clinical Pharmacology Unit, Alicante General University Hospital, 03010 Alicante, Spain.

Jordi Barrachina (J)

Neuropharmacology on Pain Treatment and Neurodevelopmental Disorders, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.

Javier Muriel (J)

Neuropharmacology on Pain Treatment and Neurodevelopmental Disorders, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Clinical Pharmacology, Pediatrics and Organic Chemistry Department, Miguel Hernández University of Elche (UMH), 03202 Alicante, Spain.

Enrique Ramos (E)

Bioengineering Institute, Pediatrics and Organic Chemistry Department, Miguel Hernández University of Elche (UMH), 03202 Alicante, Spain.

Natalia Toral (N)

San Rafael Center-San Francisco De Borja Foundation, Residential Facility, 03559 Alicante, Spain.

César Belda (C)

Infanta Leonor Center, Autism Parents Association Valencian Community Autism Association (APACV), 03010 Alicante, Spain.

Ana M Peiró (AM)

Bioengineering Institute, Pediatrics and Organic Chemistry Department, Miguel Hernández University of Elche (UMH), 03202 Alicante, Spain.
Neuropharmacology on Pain Treatment and Neurodevelopmental Disorders, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.
Clinical Pharmacology Unit, Alicante General University Hospital, 03010 Alicante, Spain.
Clinical Pharmacology, Pediatrics and Organic Chemistry Department, Miguel Hernández University of Elche (UMH), 03202 Alicante, Spain.

Classifications MeSH